Medullary thyroid carcinoma presenting with an initial CEA elevation

Background:  Carcinoembryonic antigen (CEA) is a tumour marker commonly associated with gastrointestinal malignancy. Patients presenting with an elevated CEA will therefore often undergo extensive investigations in order to elucidate an underlying gastrointestinal malignancy that may not be clinical...

Full description

Saved in:
Bibliographic Details
Published in:ANZ journal of surgery Vol. 80; no. 11; pp. 831 - 833
Main Authors: Abraham, Deepak, Delbridge, Leigh, Clifton-Bligh, Roderick, Clifton-Bligh, Phillip, Grodski, Simon, Robinson, Bruce G., Messina, Marinella, Sidhu, Stan
Format: Journal Article
Language:English
Published: Melbourne, Australia Blackwell Publishing Asia 01-11-2010
Blackwell Publishing Ltd
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background:  Carcinoembryonic antigen (CEA) is a tumour marker commonly associated with gastrointestinal malignancy. Patients presenting with an elevated CEA will therefore often undergo extensive investigations in order to elucidate an underlying gastrointestinal malignancy that may not be clinically apparent. However the GI tract is not the only source of CEA elevation. Methods:  We present a series of patients presenting with raised CEA levels that were initially investigated for a gastrointestinal cause, but after work up were detected to have medullary thyroid cancer. Results:  Four patients with raised CEA were evaluated for a gastrointestinal cause for the elevation. We discuss the non gastrointestinal causes for an elevated CEA. Conclusion:  The paper highlights that in patients presenting with an elevated CEA, in whom a gastrointestinal cause has been ruled out, a tumour of neuroendocrine origin needs to be considered as a cause for the elevated CEA.
Bibliography:ArticleID:ANS5350
istex:ADB174D3C042E85EB4BCCC0BB2190EE61B754B13
ark:/67375/WNG-0Z8015PG-V
PhD, FRACS.
S. Grodski
MD, FRACP
MBBS, FRACS
B. G. Robinson
S. Sidhu
MD, FRACS
M. Messina
Stan Sidhu is a NSW Cancer Institute Fellow.
Deepak Abraham is an Endeavour Foundation scholarship recipient.
P. Clifton‐Bligh
L. Delbridge
R. Clifton‐Bligh
PhD
D. Abraham
MBBS, MS
PhD, FRACP
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1445-1433
1445-2197
DOI:10.1111/j.1445-2197.2010.05350.x